Health & Fitness
Health and Fitness
Health and Fitness
Tue, December 16, 2008
Mon, December 15, 2008 
WILMINGTON, N.C.--([ BUSINESS WIRE ])--PPD, Inc. (Nasdaq: PPDI) today announced that effective December 22, 2008, the company will be added to the NASDAQ-100 Index®. PPD's common shares will also be included in the PowerShares QQQTM (Nasdaq: QQQQ).
"This is a defining moment in PPD's history of growth, and we are honored to be included in the prestigious NASDAQ-100 Index," said Fred Eshelman, chief executive officer of PPD. "This achievement is the result of the commitment and dedication of our employees around the world to delivering high quality services to our clients."
The NASDAQ-100 Index, launched in 1985, represents the largest, non-financial companies listed on The NASDAQ Stock Market based on market capitalization. Index securities are ranked by market value and evaluated annually to determine which securities will be included. The PowerShares QQQrepresents ownership in the NASDAQ-100 Trust and is designed to provide investment results that generally correspond to the price and yield of the NASDAQ-100 Index.
PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 33 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at [ http://www.ppdi.com ].
Except for historical information, all of the statements, expectations and assumptions contained in this news release, including expectations and assumptions about the value of being included in the NASDAQ-100 Index and the ability of PPD to remain in this Index, are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: success in sales growth; loss of large contracts; increased cancellation rates; economic conditions and outsourcing trends in the pharmaceutical, biotechnology, medical device, academic and government industry segments; competition within the outsourcing industry; risks associated with the development and commercialization of drugs, including earnings dilution and obtaining regulatory approvals; risks associated with and dependence on collaborative relationships; rapid technological advances that make our products and services less competitive; competition from related products; the ability to attract and retain key personnel; risks associated with acquisitions and investments, such as impairments; risks that we may not continue our dividend policy; and the other risk factors set forth from time to time in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.
